Literature DB >> 29111672

Deciphering Conformational Changes Associated with the Maturation of Thrombin Anion Binding Exosite I.

Ramya Billur1, David Ban2, T Michael Sabo2, Muriel C Maurer1.   

Abstract

Thrombin participates in procoagulation, anticoagulation, and platelet activation. This enzyme contains anion binding exosites, ABE I and ABE II, which attract regulatory biomolecules. As prothrombin is activated to thrombin, pro-ABE I is converted into mature ABE I. Unexpectedly, certain ligands can bind to pro-ABE I specifically. Moreover, knowledge of changes in conformation and affinity that occur at the individual residue level as pro-ABE I is converted to ABE I is lacking. Such changes are transient and were not captured by crystallography. Therefore, we employed nuclear magnetic resonance (NMR) titrations to monitor development of ABE I using peptides based on protease-activated receptor 3 (PAR3). Proton line broadening NMR revealed that PAR3 (44-56) and more weakly binding PAR3G (44-56) could already interact with pro-ABE I on prothrombin. 1H-15N heteronuclear single-quantum coherence NMR titrations were then used to probe binding of individual 15N-labeled PAR3G residues (F47, E48, L52, and D54). PAR3G E48 and D54 could interact electrostatically with prothrombin and tightened upon thrombin maturation. The higher affinity for PAR3G D54 suggests the region surrounding thrombin R77a is better oriented to bind D54 than the interaction between PAR3G E48 and thrombin R75. Aromatic PAR3G F47 and aliphatic L52 both reported on significant changes in the chemical environment upon conversion of prothrombin to thrombin. The ABE I region surrounding the 30s loop was more affected than the hydrophobic pocket (F34, L65, and I82). Our NMR titrations demonstrate that PAR3 residues document structural rearrangements occurring during exosite maturation that are missed by reported X-ray crystal structures.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29111672      PMCID: PMC6076386          DOI: 10.1021/acs.biochem.7b00970

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  63 in total

Review 1.  NMR methods for the determination of protein-ligand dissociation constants.

Authors:  Lee Fielding
Journal:  Curr Top Med Chem       Date:  2003       Impact factor: 3.295

2.  Effect of Na+ binding on the conformation, stability and molecular recognition properties of thrombin.

Authors:  Vincenzo De Filippis; Elisa De Dea; Filippo Lucatello; Roberta Frasson
Journal:  Biochem J       Date:  2005-09-01       Impact factor: 3.857

3.  Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism.

Authors:  Jeffrey I Weitz; Anthonie W A Lensing; Martin H Prins; Rupert Bauersachs; Jan Beyer-Westendorf; Henri Bounameaux; Timothy A Brighton; Alexander T Cohen; Bruce L Davidson; Hervé Decousus; Maria C S Freitas; Gerlind Holberg; Ajay K Kakkar; Lloyd Haskell; Bonno van Bellen; Akos F Pap; Scott D Berkowitz; Peter Verhamme; Philip S Wells; Paolo Prandoni
Journal:  N Engl J Med       Date:  2017-03-18       Impact factor: 91.245

4.  HD1, a thrombin-directed aptamer, binds exosite 1 on prothrombin with high affinity and inhibits its activation by prothrombinase.

Authors:  Colin A Kretz; Alan R Stafford; James C Fredenburgh; Jeffrey I Weitz
Journal:  J Biol Chem       Date:  2006-10-17       Impact factor: 5.157

Review 5.  The two-dimensional transferred nuclear Overhauser effect: theory and practice.

Authors:  A P Campbell; B D Sykes
Journal:  Annu Rev Biophys Biomol Struct       Date:  1993

6.  Rational design of potent, small, synthetic allosteric inhibitors of thrombin.

Authors:  Preetpal Singh Sidhu; Aiye Liang; Akul Y Mehta; May H Abdel Aziz; Qibing Zhou; Umesh R Desai
Journal:  J Med Chem       Date:  2011-07-18       Impact factor: 7.446

Review 7.  Reversal of Direct Oral Anticoagulants: Current Status and Future Directions.

Authors:  Jeffrey I Weitz
Journal:  Semin Respir Crit Care Med       Date:  2017-02-16       Impact factor: 3.119

8.  Ligand binding to anion-binding exosites regulates conformational properties of thrombin.

Authors:  Marina V Malovichko; T Michael Sabo; Muriel C Maurer
Journal:  J Biol Chem       Date:  2013-02-01       Impact factor: 5.157

9.  The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships.

Authors:  W Bode; D Turk; A Karshikov
Journal:  Protein Sci       Date:  1992-04       Impact factor: 6.725

10.  The structure of a complex of recombinant hirudin and human alpha-thrombin.

Authors:  T J Rydel; K G Ravichandran; A Tulinsky; W Bode; R Huber; C Roitsch; J W Fenton
Journal:  Science       Date:  1990-07-20       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.